Success is a collaborative effort…
BioDerm’s executive team has increased sales revenue by over 40% each year since 2011, more than doubled staff to support growth, expanded manufacturing, and updated its technology to improve efficiency and facilitate growth. Most recently, the Premier Healthcare Alliance—which serves more than 3,000 hospitals in the U.S.—awarded BioDerm a contract as national provider of securement devices for drainage and catheters, replacing CR Bard, the 20-year incumbent provider. Better products yield better results!
In addition, we have:
- Helped improve the lives of tens of thousands of incontinent men
- Expanded product sales to over 400 domestic hospitals
- Secured 8 US and international patents protecting our innovative designs and intellectual property
- Grown direct-to-consumer advertising programs, generating a record number of new customers each month at a highly competitive cost per acquisition
- Established new partnerships with major U.S. and international distribution partners to expand product penetration into the acute care market
- Expanded call center operations to handle increased customer volumes; updated technology and introduced a Noble Dialer system
- Installed an updated, secure CRM solution to manage client files safely and ensure that minimum necessary HIPAA guidelines for data security are exceeded
- Successfully launched and maintained a content marketing program that has established BioDerm as an industry thought leader; pioneered direct-to-consumer blogging and social media campaigns on incontinence that have cultivated a growing following
- Launched a new catheter securement product line to expand reach into the acute care and hospital market
- Introduced manufacturing automation in 2014 to improve quality
- Successfully completed ISO-13485 certification for manufacturing and exporting to major international markets
- Achieved MFDS (KFDA)South Korean regulatory certification
- Launched a new penile clamp product in 2014 for the out-patient market
- Reduced carbon footprint by replacing the majority of our products’ plastic packaging with recycled and biodegradable materials
- Joined the Mission:ABLE partnership with the Paralyzed Veterans of America (PVA)
- Registered with the Better Business Bureau and maintained an A+ rating
- Diversified international revenue to approximately 5% of annual revenue
Gary Damkoehler, Chairman and Chief Executive Officer
Damkoehler is a veteran healthcare industry executive and former Chairman of the Board of JSA Healthcare Corporation. After successful stints at USAID and Westinghouse’s Health Systems Division, he joined the predecessor company to JSA in 1984. Damkoehler founded JSA’s Government Services Division, which grew from $120,000 in sales in 1984 to $21.4 million in 1994, an achievement that placed the company on the Inc. 500 List. He was appointed President of JSA in 1985 and Chairman of the Board in 1988. In 1992, he led JSA into the managed care arena, growing to 65 facilities and revenues of $210 million in 2005. Damkoehler holds a Bachelor’s degree in Economics from the University of Alabama and a Masters degree in Economics from the University of Alabama.
Gaet Tyranski, PresidentTyranski is a global P&L Executive with a proven track record of organic and inorganic growth, continuous improvement, customer satisfaction and employee development. He is a veteran of multiple rapid-growth organizations, including start-ups and multi-million-dollar healthcare manufacturers and service providers including Jabil Circuit, Inc. and Synergy Health plc. Gaet has extensive international experience having resided in China, Hong Kong, England, Scotland, Italy and Austria (commuting to Hungary) during his career. Tyranski is responsible for accelerating BioDerm’s aggressive growth plans, will oversee BioDerm’s diverse manufacturing and R&D portfolio, ensure strict FDA compliance and support BioDerm’s B2B, B2C and international marketing and sales efforts. Gaet holds a Bachelor’s degree in Economics and Political Science from Bucknell University and a Master of Business Administration from the University of Florida, Gainesville. He is also a Board Member of the Florida Medical Manufacturers Consortium (FMMC).
Shawn Stone, Vice President of OperationsStone has more than 20 years of experience in operations, materials, supply chain and project management, with an emphasis on regulated industries including aerospace and medical device. His background has led to full knowledge of ERP system conversions, MRP, Demand Planning, Mil standards, GSI, FAR, DFARS, cGMP and GDP, ISO 13485, ISO 9001, AS 9100, OHSAS 80001, and ISO 14001. Lean trained by Boeing, Stone is a Certified Six Sigma Black Belt who is proficient in resolving and implementing Corrective and Preventative Actions (CAPAs). Shawn developed the ability to lead cross functional teams, implement ISO systems, train employees on standards, identify cost savings opportunities through Six Sigma, and manage projects to increase productivity and improve performance.
Prior to joining Bioderm in 2016, Stone was Operations Manager at Synergy Health, and has held various management positions at Chromalloy Gas Turbine and Smiths Medical. Shawn received his Bachelor of Arts in Business from Aurora University, Aurora, Illinois.
Wendy LaTorre, Chief Strategy OfficerLaTorre is a marketing and sales executive with more than 20 years of experience, including 16 years in the direct response industry. Since joining BioDerm in 2012, she has developed and led branding and marketing efforts that have boosted company and product awareness and supported sales revenue growth by more than 50% each year. LaTorre’s expertise in branding and mass marketing also is reflected in the successful product projects she oversaw from idea conception to distribution for Tony Little and other boutique brands. She directed a 180-employee division of the national fitness chain Lifestyle Family Fitness, after having partnered with Tony Little on an exclusive private gym. LaTorre was previously director of marketing for a $30 million direct response company. As an entrepreneur, she created her own line of women’s fitness products that were sold successfully on HSN and in infomercials. LaTorre holds a Bachelors degree in Marketing from Eckerd College.
Jim Terpstra, National Sales Manager
Terpstra is a healthcare sales executive with an established track record of success in developing sales teams that achieve excellent results. Since joining BioDerm in 2013, Terpstra has been responsible for expanding sales of BioDerm’s revolutionary products for catheter securement and male urinary incontinence. He is overseeing expansion plans, including a move into new markets—integrated care networks, hospital systems and long-term care facilities—and has brought on several new distribution partners, secured the Premier GPO contract, and developed the company’s independent sales force from ground zero.
Terpstra was most recently Director of Corporate Accounts for Eloquest Healthcare, where he was responsible for negotiating contracts with GPOs, distributors, and integrated health networks for product distribution. During his tenure at Eloquest he developed and led a sales team that generated revenues of $2 million in new and expanded contracts and price increases.
He previously spent nine years with Sage Products, where he held leadership positions in corporate account development. He increased GPO revenue for the company’s easy-to-use, disposable products by more than 20 percent and was regularly recognized as Sales Person of the Year. The Michigan native received his Bachelor of Arts degree in Business Administration from Northwood University in Midland.
Byron Dyke, Chief Financial Officer
Dyke has 25 years of experience in corporate financial leadership in public and private enterprises encompassing start-up, developing and rapid-growth environments. His expertise spans managed growth, strategic planning, fiscal troubleshooting, mergers and acquisitions, process re-engineering. He has also overseen information technology implementations that include finance, sales force automation and customer relationship management systems.
Prior to joining BioDerm, Dyke was chief financial officer for Applicant Insight, Inc. and nomoreforms, Inc., where he developed numerous successful cost savings plans. He previously was director of accounting and finance for Hanger Orthopedic Group during their growth to a $500 million medical services and manufacturing company.
Mr. Dyke holds a Bachelor of Science degree in Business Administration/Accounting from Ohio State University.
James Harders, Ph.D., Director of EngineeringDr. Harders is a 20-year healthcare veteran specializing in R&D and process engineering. Harders joins Bioderm with extensive experience as a Manager of a Research Laboratory, a Product Development Research Scientist and a Process Engineer with pharmaceutical and medical device companies such as Allergan plc and Johnson & Johnson. Jim brings to Bioderm extensive experience with a variety of manufacturing processes for medical devices such as RF welding, laser welding, automated assembly, injection molding, extrusion of polymers, machining of metals and plastics engineering. In addition, he has extensive experience with bioresorbable polymers used for wound closure and rapid healing responses of damaged tissue.
Dr. Harders earned his Bachelor of Science degree in Human Physiology as well as his Master of Science in Biomechanical Engineering at the University of British Columbia. He then went on to complete his doctoral work in Microbiology, with an emphasis on Human Physiology, at the University of California at Santa Barbara.
Joe Carrens, Vice President of Quality & Regulatory AffairsCarrens is an FDA compliance inspection veteran with more than 35 years of experience in medical device product/process development. His expertise encompasses production, testing, validation, quality assurance (QA), regulatory affairs and FDA product submissions. Carrens oversees BioDerm’s development and implementation of all processes for new and existing product lines, including market feedback to ensure that the company is on the leading edge of male urinary management. In addition, he was instrumental in the completion of BioDerm’s ISO 13485 “Quality Systems” certification.
Carrens spent more than 10 years at Johnson & Johnson’s Critikon division, in both domestic and international management positions. Leading a team of 70 assembly employees and 20 engineers as Director of Pilot Plant Production/QA for new products, he developed a new I.V. Catheter product line. He also directed all project planning, process and product development, budgeting, and manufacturing.
As General Manager of NPAC Sterile Processing, Carrens led the start-up and operation of a new production facility providing sterile reusable products. Under his leadership, QA systems were developed for both the business and production sides of the company, including sterilization and process validation, facility engineering, managed product development, and FDA product submissions/inspections. Carrens was also Plant Manager at Surgical Services, Inc. and an independent consultant in the medical device manufacturing industry.
Carrens’ Bachelor’s of Science degree in biology is from the University of Tulsa. He is a former ASQ certified quality engineer, a former committee member at the Association for the Advancement of Medical Instrumentation (AAMI), and a former ASQ Certified Manager of Quality/Organizational Excellence (2007).
Board of Directors
Gary Damkoehler, Series A Director
Gary Damkoehler is the former Chairman of the Board of JSA Healthcare Corporation. After career success at USAID and Westinghouse’s Health Systems Division, he joined the predecessor company to JSA in 1984. He founded JSA’s Government Services Division, which grew from $120,000 in sales in 1984 to $21.4 million in 1994, a growth record that placed the company on the Inc. 500 List. Mr. Damkoehler became President of JSA in 1985 and Chairman of the Board in 1988. In 1992, JSA entered the managed care arena and grew from one facility that year to 65 facilities and revenues of $210 million in 2005. Mr. Damkoehler received his bachelor’s degree in Economics from the University of Alabama and his masters in Economics from the University of Alabama.
Robert K. Fredericks, Independent Director
Bob Fredericks has been President of BAMF Industries since 1985. BAMF markets the Exel International brand of hypodermic needles, syringes, IV catheters, infusion sets and more. Since he started the company in 1985, it has experienced 21 years of sales growth and 19 continuous years of profitability. Today the company has manufacturing facilities and offices in Florida, California, and Great Britain. Previously, Mr. Fredericks was the Vice President of Marketing and Sales for R.P. Scherer North America, and President and Chairman of The Council for Responsible Nutrition. Mr. Fredericks was the Vice President of Product Management and Marketing Services for R. Brook a Division of J&J. Over his career, Mr. Fredericks has consistently demonstrated his ability to identify opportunities, develop strategic business plans and budgets, identify the right personnel, and constantly review the business as it grows and fine tuning plans as required. Mr. Fredericks received his bachelor’s degree in Marketing from Rider University.
Gaet Tyranski, President.
Margaret Smythe March, M.D.
Retiring after 45 years as a dermatologist in private practice, Dr. March spent six years in real estate development in Pennsylvania. During this period, she served as general contractor for a group that bought, refurbished and sold eight properties. After moving to Sarasota part time in 1996 and full time in 2003, she became an investor, primarily in the biomedical area. Dr. March received her bachelor’s degree in Biology from the University of Pennsylvania and her medical doctorate from the University of Pennsylvania.
Steven S. Weiss, Series B Director
Steven Weiss has over 37 years experience in the medical device industry and presently is the Vice President of National Accounts for Future Health Concepts. Previously he was the Vice President of Corporate Accounts and OEM business for Invivo Corp from 2000-2007 and over seven years helped the company grow from $14m to $300m. In 2007 the company was purchased by Phillips for $1.3 billion. The start of his career was with Datascope Corporation from 1973-2000 where he held various positions from Director of Sales to Director of Corporate Accounts. Throughout his career Mr. Weiss has shown the ability to increase sales by developing strong sales teams along with his expertise to develop strategic corporate hospital GPO relationships. Mr. Weiss attended the Plaza School of Technology, Fairleigh Dickson University, and CW Post Long Island University.
Dr. Charles W. Mulford, CPA
Dr. Charles W. Mulford is Invesco Chair and Professor of Accounting in the College of Management at Georgia Tech. He is a founding shareholder of Cash Flow Analytics, LLC, a firm dedicated to providing software solutions for credit and investment analysis. In addition, he consults regularly with large commercial banks and investment firms. Dr. Mulford has co-authored four books on financial analysis and the warning signs of financial fraud, including the best-selling The Financial Number Game and Creative Cash Flow Reporting. Dr. Mulford has appeared on numerous broadcast networks, including CNBC, ABC News, and Bloomberg TV and is quoted regularly in numerous business publication, including the Wall Street Journal, Business Week, and CFO Magazine. Dr. Mulford has served on the Board of Directors for BioDerm, Inc. since 1999. Dr. Mulford received his Ph.D. in Accounting from Florida State University.